IRON SUPPLEMENTATION FOR ACUTE BLOOD-LOSS ANEMIA AFTER CORONARY-ARTERY BYPASS-SURGERY - A RANDOMIZED, PLACEBO-CONTROLLED STUDY

被引:0
|
作者
CROSBY, L [1 ]
PALARSKI, VA [1 ]
COTTINGTON, E [1 ]
CMOLIK, B [1 ]
机构
[1] ALLEGHENY GEN HOSP,CARDIAC & PULM REHAB SERV,PITTSBURGH,PA 15212
来源
HEART & LUNG | 1994年 / 23卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the use of oral iron replacement therapy as an effective treatment for acute surgically induced anemia. Design: Double-blind, placebo-controlled, randomized clinical trial. Setting: Perioperative acute care hospital and a surgery clinic for a single cardiothoracic physician group. Patients: One hundred twenty-eight men and postmenopausal women, 50 years of age or older, admitted for elective coronary artery bypass surgery over a consecutive 8-month period. Outcome Measures: Before surgery: serum iron, serum ferritin, hemoglobin and hematocrit. Six days after surgery: hemoglobin and hematocrit. Mean of 59 days after surgery: serum iron, serum ferritin, hemoglobin and hematocrit. Intervention: Patients were randomized to one of four groups: control group; placebo group; low-dose group, 50 mg elemental iron + 60 mg ascrobic acid in a multi-vitamin daily; and usual-dose group, 200 mg elemental iron daily. Results: One hundred twenty-one subjects completed the study: 100 men (82.6%) mean age 64.5 years and 21 women (17.4%), mean age 65.7 years. There were no statistically significant age or gender differences among groups. Statistical analysis revealed, except for side effects, no differences between or among groups for any variable measured during the last two time intervals. The mean hemoglobin and hematocrit of the entire sample at 6 days was 9.5 +/- 1.2 gm/dl and 28% +/- 2.3%, respectively. At a mean of 59 days later these values increased equally for all groups to a mean for the cohort of 13.6 +/- 1 gm/dl for hemoglobin and 40.6% +/- 3 for hematocrit. Serum iron and ferritin were within the normal range. The 200 mg group experienced significantly more side effects (p < 0.01). Conclusion: Thus the use of oral iron supplements for the treatment of acute blood loss anemia after uncomplicated coronary artery bypass surgery did not assist in restoring red blood cell mass or help maintain total body iron stores.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 50 条
  • [21] EFFECTS OF ADENOSINE AFTER CORONARY-ARTERY BYPASS-SURGERY
    FUKUNAGA, AF
    MIYAMOTO, T
    ANESTHESIA AND ANALGESIA, 1992, 75 (01): : 148 - 149
  • [22] MASSIVE CHYLOPERICARDIUM AFTER CORONARY-ARTERY BYPASS-SURGERY
    PELLEGRINI, RV
    TRAVERS, DJ
    MARRANGONI, AG
    DIMARCO, RF
    BEKOE, S
    GRANT, KJ
    WOELFEL, GF
    TEXAS HEART INSTITUTE JOURNAL, 1987, 14 (03) : 318 - 320
  • [25] NON-RANDOMIZED STUDIES OF CORONARY-ARTERY BYPASS-SURGERY
    DETRE, KM
    STATISTICS IN MEDICINE, 1984, 3 (04) : 389 - 398
  • [26] Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
    Leino, Kari
    Hynynen, Markku
    Jalonen, Jouko
    Salmenpera, Markku
    Scheinin, Harry
    Aantaa, Riku
    BMC ANESTHESIOLOGY, 2011, 11
  • [27] RELATION OF PREOPERATIVE USE OF ASPIRIN TO INCREASED MEDIASTINAL BLOOD-LOSS AFTER CORONARY-ARTERY BYPASS GRAFT SURGERY
    MICHELSON, EL
    MORGANROTH, J
    TOROSIAN, M
    MACVAUGH, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1978, 76 (05): : 694 - 697
  • [28] Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
    Kari Leino
    Markku Hynynen
    Jouko Jalonen
    Markku Salmenperä
    Harry Scheinin
    Riku Aantaa
    BMC Anesthesiology, 11
  • [29] EFFECT OF POSTOPERATIVE IMMOBILIZATION AFTER CORONARY-ARTERY BYPASS-SURGERY
    CHULAY, M
    BROWN, J
    SUMMER, W
    CRITICAL CARE MEDICINE, 1982, 10 (03) : 176 - 179
  • [30] EFFECTS OF ADENOSINE AFTER CORONARY-ARTERY BYPASS-SURGERY - REPLY
    RICKSTEN, SE
    ANESTHESIA AND ANALGESIA, 1992, 75 (01): : 149 - 150